🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Related News

Specialty chemicals startup Scimplify raises $40 Mn in Series B round

EntrackrEntrackr · 4m ago
Specialty chemicals startup Scimplify raises $40 Mn in Series B round
Medial

Scimplify, a platform for sourcing and manufacturing specialty chemicals, has raised $40 million in a Series B funding round co-led by Accel and Bertelsmann India Investments, with participation from UMI and existing investors, including Omnivore and 3one4 Capital. This funding brings Scimplify’s total capital raised to $54 million, following its seed and Series A rounds. The fresh capital will accelerate Scimplify’s export expansion beyond the 16 countries it currently serves while strengthening its presence in key industries such as life sciences, crop sciences, and industrial chemicals, the company said in a press release. Many manufacturers struggle with sourcing raw materials, navigating regulatory requirements, and scaling up production to meet global demand. Scimplify addresses these challenges by offering an end-to-end manufacturing ecosystem, combining in-house scientific expertise with a network of over 200 specialized manufacturing plants across cost-efficient regions in India. Founded by Salil Srivastava and Sachin Santhosh, Scimplify is a B2B fulfillment platform that operates across the product life cycle, from contract research to commercial chemical manufacturing, serving industries such as pharmaceuticals, personal care, and agrochemicals. The company’s plug-and-play model enables global buyers to leverage India’s cost-efficient production capabilities without the burden of setting up dedicated manufacturing facilities. “As global supply chains undergo rapid shifts, customers are actively seeking reliable partners who can provide enterprise-grade R&D and comprehensive solutions for their specialty chemical manufacturing needs. Over the past year and a half, we have built great momentum, and with Accel joining this partnership, we remain steadfast in building a global R&D-led manufacturing company that brings a new-age approach to the modern customer,” said Srivastava. The Bengaluru-based company serves major markets, including the US, Europe, and Japan. Scimplify competes with Mstack, Atomgrid, Covvalent, Distil, and Elchemy.

Deeptech manufacturing startup Leumas raises $2.2 Mn in Seed round

EntrackrEntrackr · 1m ago
Deeptech manufacturing startup Leumas raises $2.2 Mn in Seed round
Medial

Deeptech manufacturing startup Leumas has raised $2.2 million in a seed funding round led by Capital 2B, a deeptech-focused fund backed by Info Edge and Temasek, along with participation from Capital-A and Anicut Capital. The proceeds will be used to expand its R&D capabilities, scale on-demand manufacturing infrastructure, and launch pilot deployments of dedicated factories for wellness and pharma brands, Leumas said in a press release. Co-founded in 2016 by Subhajit Biswas and Nitesh K, Leumas offers on-demand manufacturing and factory-as-a-service models for wellness and pharma brands. Its solution is built on software-defined, modular robot factories that radically improve manufacturing and business outcomes - from development to commercial production. By combining automation, software intelligence, and R&D, it helps brands scale quickly, maintain quality, and reduce risk. According to Leumas, its core product is cyber-physical manufacturing technology: software-driven, modular production lines that integrate AI-led robotics, vision-based quality systems, and autonomous operations to ensure optimal production output and regulatory compliance. As per market research, the outsourced development and manufacturing market for pharma and wellness is expected to exceed $400 billion by 2030. Over the past year, Leumas claims to have co-developed its manufacturing solution with leading wellness brands and has helped scale more than 120 products across India, the US, and MENA. It has also signed agreements with prominent pharma and food research institutions to build dedicated factory capacities using its modular factory solution.

Download the medial app to read full posts, comements and news.